Clinical Guidance - Drug Class Reviews - Pharmacy Benefits Management Services
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Pharmacy Benefits Management Services

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Clinical Guidance - Drug Class Reviews

Angiotensin II Receptor Antagonists, Drug Class Review
Anticholinergics for OAB Syndrome Class Review
Anticoagulants, Target Specific Oral (TSOACs) Dabigatran, Rivaroxaban, Apixaban Drug Class Review (Rev. Dec. 2014)
Antihistamine - Ophthalmic (Mast Cell Stabilizing Agents), Drug Class Review
Antihistamines - Nonsedating, Drug Class Review
Bisphosphonates, Drug Class Review
Botulinum Toxins, Drug Class Review
Corticosteroids-Intranasal, Drug Class Review
DMARDs for Rheumatoid Arthritis (Anti-TNF DMARD) Drug Class Review Update
Dopamine Agonists, Drug Class Review
DPP-4 Inhibitor Drug Class Review
Glycoprotein (GP) IIb - IIIa Receptor Inhibitors, Drug Class Review
HMG CoA Reductase Inhibitors (Statins), Drug Class Review and Appendices
Hormone Therapy - Combined Estrogen Progestin, Abbreviated Drug Class Review
Hyaluronic acid-Hylan G-F 20 for Osteoarthritis of the Knee-Final Review (May 2008)
LHRH Agonists (Gynecologic Disorders), Drug Class Review
LHRH Agonists (Prostate Cancer), Drug Class Review
Long-acting beta-agonist and Inhaled Corticosteroid Combination Inhalers
Ophthalmic Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Review
Opthalmic NSAIDs-Addendum to Drug Class Review (Focus on Agents with Less Frequent Dosing)
Ophthalmic Prostaglandin Analog Drug Class Review Update
PDE5 Inhibitors (Erectile Dysfunction), Drug Class Review
Prostaglandin Analogs - Ophthalmic, Drug Class Review
Proton Pump Inhibitors, Abbreviated Drug Class Review
Pulmonary Arterial Hypertension (PAH), Pharmacologic Management